• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The elucidation of renal cell carcinoma progression through ELOVLs-mediated lipid metabolism

Research Project

Project/Area Number 19K09664
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 56030:Urology-related
Research InstitutionUniversity of Tsukuba

Principal Investigator

Kandori Shuya  筑波大学, 医学医療系, 講師 (50707825)

Co-Investigator(Kenkyū-buntansha) 池田 篤史  筑波大学, 附属病院, 病院講師 (50789146)
松坂 賢  筑波大学, 医学医療系, 教授 (70400679)
河合 弘二  筑波大学, 人間総合科学研究科, 講師 (90272195)
Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2021: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords腎癌 / 脂肪酸伸長酵素 / ELOVL2 / ELOVL5 / 淡明型腎細胞癌 / ELOVL / 脂質代謝 / ELOLV5
Outline of Research at the Start

腎癌の代表的な組織型である淡明型腎細胞癌(ccRCC)は細胞内脂質が豊富であることが特徴である。がんにおいて脂質合成が亢進し(脂質の「量」)、がんの生存に寄与することが示されてる一方で、脂質の「質」の役割については未だ不明な点が多い。我々はccRCCの進展に脂質の質的変容が重要な役割を果たすという仮説のもと、脂肪酸伸長酵素であるELOVLs
に着目した。本研究ではccRCCにおいて、これらの脂肪酸伸長酵素ELOVLsが脂質の三大機能である生体膜成分、エネルギー源、シグナル伝達分子としての機能に及ぼす影響とがんの増殖や浸潤を促進する機序を明らかにし、新規治療戦略の開発につなげることを目的とする。

Outline of Final Research Achievements

The elongation of very long chain fatty acid (ELOVL) catalyzes the elongation of fatty acids (FAs), and is required for normal bodily functions. A hallmark of clear cell renal cell carcinoma (ccRCC) is the presence of intracellular lipid droplets (LDs). However, the roles of ELOVL remain unexplored in ccRCC. We previously showed that ELOVL2 was highly expressed in ccRCC. Furthermore, a higher level of ELOVL2 was significantly associated with a poor prognosis of patients with ccRCC. The knockout of ELOVL2 resulted in the suppression of the elongation of long chain polyunsaturated FAs and decreased LDs production in renal cancer cells. Moreover, ELOVL2 ablation resulted in the suppression of cellular proliferation via the induction of apoptosis in vitro and the attenuation of tumor growth in vivo. Collectively, the present study provides new insight into the tumor proliferation mechanisms involving lipid metabolism, and suggests that ELOVL2 may be a novel target for ccRCC therapy.

Academic Significance and Societal Importance of the Research Achievements

進行腎癌に対しては、分子標的薬や免疫チェックポイント阻害薬が開発されてきたが、完全寛解に至る症例はまれである。脂質解析技術の発展とともに脂質の質的変容による生理活性が明らかになりつつが、がんの領域では未だ十分な解析が行われていないのが実情である。本研究では脂肪酸伸展酵素ELOVL2,5による脂質の質的変容を介した腎癌の進展メカニズムの解明と新規治療戦略の確立を目的としている。ELOVL2,5-KOマウスは致死的及び臓器形成異常などのphenotypeは認めず、臨床応用の際に有利である。本研究を通じて新規治療法が確立されれば、進行腎癌における治療戦略に重大なインパクトを与えることが期待される。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (21 results)

All 2022 2021 2020 2019

All Journal Article (17 results) (of which Peer Reviewed: 17 results,  Open Access: 4 results) Presentation (4 results)

  • [Journal Article] Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era ? a multi-institutional retrospective study2022

    • Author(s)
      Kato Renpei、Naito Sei、Numakura Kazuyuki、Hatakeyama Shingo、Koguchi Tomoyuki、Kojima Takahiro、Kawasaki Yoshihide、Kandori Shuya、Kawamura Sadafumi、Arai Yoichi、Ito Akihiro、Nishiyama Hiroyuki、Kojima Yoshiyuki、Ohyama Chikara、Habuchi Tomonori、Tsuchiya Norihiko、Obara Wataru
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 27 Issue: 3 Pages: 563-573

    • DOI

      10.1007/s10147-021-02091-8

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era2021

    • Author(s)
      Naito Sei、Kato Tomoyuki、Numakura Kazuyuki、Hatakeyama Shingo、Koguchi Tomoyuki、Kandori Shuya、Kawasaki Yoshihide、Adachi Hisanobu、Kato Renpei、Narita Shintaro、Yamamoto Hayato、Ogawa Soichiro、Kawamura Sadafumi、Obara Wataru、Ito Akihiro、Nishiyama Hiroyuki、Kojima Yoshiyuki、Ohyama Chikara、Habuchi Tomonori et al
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 26 Issue: 10 Pages: 1947-1954

    • DOI

      10.1007/s10147-021-01979-9

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era2021

    • Author(s)
      Numakura Kazuyuki、Muto Yumin、Naito Sei、Hatakeyama Shingo、Kato Renpei、Koguchi Tomoyuki、Kojima Takahiro、Kawasaki Yoshihide、Kandori Syuya、Kawamura Sadafumi、Arai Yoichi、Ito Akihiro、Nishiyama Hiroyuki、Kojima Yoshiyuki、Obara Wataru、Ohyama Chikara、Tsuchiya Norihiko、Habuchi Tomonori
    • Journal Title

      Cancer Medicine

      Volume: 10 Issue: 17 Pages: 5839-5846

    • DOI

      10.1002/cam4.4130

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study2021

    • Author(s)
      Okita Kazutaka、Hatakeyama Shingo、Naito Sei、Numakura Kazuyuki、Kato Renpei、Koguchi Tomoyuki、Kojima Takahiro、Kawasaki Yoshihide、Kandori Shuya、Kawamura Sadafumi、Nishiyama Hiroyuki、Ito Akihiro、Kojima Yoshiyuki、Habuchi Tomonori、Obara Wataru、Tsuchiya Norihiko、Ohyama Chikara
    • Journal Title

      Urologic Oncology: Seminars and Original Investigations

      Volume: 39 Issue: 12 Pages: 836.e11-836.e17

    • DOI

      10.1016/j.urolonc.2021.08.015

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma2021

    • Author(s)
      Tanaka Ken、Kandori Shuya、Sakka Shotaro、Nitta Satoshi、Tanuma Kozaburo、Shiga Masanobu、Nagumo Yoshiyuki、Negoro Hiromitsu、Kojima Takahiro、Mathis Bryan、Shimazui Toru、Watanabe Makoto、Sato Taka-Aki、Miyamoto Takafumi、Matsuzaka Takashi、Shimano Hitoshi、Nishiyama Hiroyuki
    • Journal Title

      Oncology Reports

      Volume: 47 Issue: 2 Pages: 23-23

    • DOI

      10.3892/or.2021.8234

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Retroperitoneal lymph node dissection for testicular cancer in a patient with a double inferior vena cava2021

    • Author(s)
      Yamaguchi Akane、Negoro Hiromitsu、Kojo Kosuke、Ikeda Atsushi、Kimura Tomokazu、Kandori Shuya、Hoshi Akio、Kojima Takahiro、Kawai Koji、Nishiyama Hiroyuki
    • Journal Title

      IJU Case Reports

      Volume: 4 Issue: 2 Pages: 86-88

    • DOI

      10.1002/iju5.12247

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future2020

    • Author(s)
      Kimura Tomokazu、Ishikawa Hitoshi、Kojima Takahiro、Kandori Shuya、Kawahara Takashi、Sekino Yuta、Sakurai Hideyuki、Nishiyama Hiroyuki
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 50 Issue: 10 Pages: 1097-1107

    • DOI

      10.1093/jjco/hyaa155

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Editorial Comment to Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy2020

    • Author(s)
      Kandori Shuya
    • Journal Title

      IJU Case Reports

      Volume: 3 Issue: 6 Pages: 274-274

    • DOI

      10.1002/iju5.12222

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Impact of centralization in primary retroperitoneal sarcoma treatment: analysis using hospital-based cancer registry data in Japan2020

    • Author(s)
      Kimura Tomokazu、Kawai Koji、Kandori Shuya、Nitta Satoshi、Kojo Kosuke、Nagumo Yoshiyuki、Negoro Hiromitsu、Okuyama Ayako、Higashi Takahiro、Kojima Takahiro、Nishiyama Hiroyuki
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 25 Issue: 9 Pages: 1687-1694

    • DOI

      10.1007/s10147-020-01709-7

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan2020

    • Author(s)
      Nagumo Yoshiyuki、Kawai Koji、Kojima Takahiro、Shiga Masanobu、Kojo Kosuke、Tanaka Ken、Kandori Shuya、Kimura Tomokazu、Kawahara Takashi、Okuyama Ayako、Higashi Takahiro、Nishiyama Hiroyuki
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 50 Issue: 9 Pages: 1068-1075

    • DOI

      10.1093/jjco/hyaa072

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Prognostic impact of non‐urothelial carcinoma of the upper urinary tract: Analysis of hospital‐based cancer registry data in Japan2020

    • Author(s)
      Nagumo Yoshiyuki、Kawai Koji、Kojima Takahiro、Shiga Masanobu、Kojo Kosuke、Tanaka Ken、Kandori Shuya、Kimura Tomokazu、Kawahara Takashi、Okuyama Ayako、Higashi Takahiro、Nishiyama Hiroyuki
    • Journal Title

      International Journal of Urology

      Volume: 28 Issue: 1 Pages: 54-60

    • DOI

      10.1111/iju.14393

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Recent malignant testicular tumor trend in Japan, a country with an aging population: a large-scale study of 2012?2015 hospital-based cancer registry data2020

    • Author(s)
      Kojo Kosuke、Kawai Koji、Kawahara Takashi、Kimura Tomokazu、Kandori Shuya、Nagumo Yoshiyuki、Nitta Satoshi、Kojima Takahiro、Okuyama Ayako、Higashi Takahiro、Nishiyama Hiroyuki
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 50 Issue: 10 Pages: 1201-1208

    • DOI

      10.1093/jjco/hyaa110

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study2020

    • Author(s)
      Hatakeyama Shingo、Naito Sei、Numakura Kazuyuki、Kato Renpei、Koguchi Tomoyuki、Kojima Takahiro、Kawasaki Yoshihide、Kandori Shuya、Kawamura Sadafumi、Tsushima Eiki、Nishiyama Hiroyuki、Ito Akihiro、Kojima Yoshiyuki、Habuchi Tomonori、Obara Wataru、Tsuchiya Norihiko、Ohyama Chikara
    • Journal Title

      International Journal of Urology

      Volume: 28 Issue: 4 Pages: 369-375

    • DOI

      10.1111/iju.14466

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Predictors of venous thromboembolism development before and during chemotherapy for advanced germ cell tumor2020

    • Author(s)
      Nitta Satoshi、Kawai Koji、Kimura Tomokazu、Kawahara Takashi、Kandori Shuya、Hoshi Akio、Kojima Takahiro、Nishiyama Hiroyuki
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 50 Issue: 3 Pages: 338-343

    • DOI

      10.1093/jjco/hyz177

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] The updated points of TNM classification of urological cancers in the 8th edition of AJCC and UICC2019

    • Author(s)
      Kandori Shuya、Kojima Takahiro、Nishiyama Hiroyuki
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 49 Issue: 5 Pages: 421-425

    • DOI

      10.1093/jjco/hyz017

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer2019

    • Author(s)
      Kawahara Takashi、Kojima Takahiro、Kandori Shuya、Kurobe Masahiro、Yoshino Takayuki、Kimura Tomokazu、Nagumo Yoshiyuki、Ishituka Ryutaro、Mitsuzuka Koji、Narita Shintaro、Kobayashi Takashi、Matsui Yoshiyuki、Ogawa Osamu、Sugimoto Mikio、Miyazaki Jun、Nishiyama Hiroyuki
    • Journal Title

      PLOS ONE

      Volume: 14 Issue: 8 Pages: 220173-220173

    • DOI

      10.1371/journal.pone.0220173

    • NAID

      120007133062

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Impact of hemoglobin levels on hemoglobin-adjusted carbon monoxide diffusion capacity after chemotherapy for testicular cancer2019

    • Author(s)
      Nitta Satoshi、Kawai Koji、Nagumo Yoshiyuki、Ikeda Atsushi、Kandori Shuya、Kojima Takahiro、Nishiyama Hiroyuki
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 49 Issue: 12 Pages: 1151-1156

    • DOI

      10.1093/jjco/hyz103

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Presentation] 脂肪酸伸長酵素ELOVL5による腎癌の進展メカニズムの解明2022

    • Author(s)
      新田聡、神鳥周也、目翔太郎、田中建、西山博之
    • Organizer
      第31回 泌尿器科分子・細胞研究会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ELOVL5による腎癌の進展メカニズムの解明2021

    • Author(s)
      新田聡、神鳥周也、田沼光三郎、志賀正宣、田中建、南雲義之、小島崇宏、西山博之
    • Organizer
      第109回 日本癌学会学術総会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ELOVL2の発現亢進は腎癌の進展に関与する2019

    • Author(s)
      田中建、神鳥周也、小島崇宏、河原貴史、河合弘二、西山博之
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Research-status Report
  • [Presentation] TB08601275<Pre 医中誌> FGFRシグナルの活性化機序により膀胱癌の腫瘍内免疫環境が異なる2019

    • Author(s)
      河原貴史、小島崇宏、志賀正宣、田中建、神鳥周也、木村友和、河合弘二、西山博之
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Research-status Report

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi